Drawing for P OXFORD PHARMAGENESIS THE HEALTHSCIENCE COMMUNICATORS

USPTO serial 79171690

P OXFORD PHARMAGENESIS THE HEALTHSCIENCE COMMUNICATORS

Reviewed by CopyMark Law Group

Reg. 5515951Status 739Registered
Filing date
Status date
Registration date
Jul 17, 2018
Examiner
BROWN, BARBARA TROFFKIN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with P OXFORD PHARMAGENESIS THE HEALTHSCIENCE COMMUNICATORS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine K. Madianos

Katherine K. Madianos Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable electronic publications in the nature of peer-reviewed journals in the healthcare, pharmaceutical and scientific field; Downloadable e-books in the healthcare, pharmaceutical, and scientific field; audio recordings featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; video recordings featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable MP3 featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine.; Software that functions to make accessible to, inform, and educate clients on peer-reviewed health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; application Software that functions to make accessible to, inform, and educate clients on peer-reviewed health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; educational Software that functions to make accessible to, inform, and educate clients on peer-reviewed health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable databases featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable electronic databases featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable computer databases featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Optical compact discs featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; blank magnetic discs, blank optical discs, blank data cassettes, and blank magnetic computer tapes, all featuring the ability to record, store, and transmit sound, video, images, and data in the healthcare, pharmaceutical, and scientific field; all for others, and all in the healthcare, pharmaceutical and scientific fieldACTIVE—
016Printed matter and printed publications, namely, brochures and booklets in the healthcare, pharmaceutical, and scientific field; Books in the healthcare, pharmaceutical, and scientific field; Magazines in the healthcare, pharmaceutical, and scientific field; Newsletters in the healthcare, pharmaceutical, and scientific field; Journals in the healthcare, pharmaceutical, and scientific field; Printed periodicals in the healthcare, pharmaceutical, and scientific field; almanacs; diaries; calendars; advertising publicity and promotional materials, namely, pamphlets, signs, brochures, leaflets, or informational sheets about the healthcare, pharmaceutical, and scientific field; Manuals featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Event programs in the healthcare, pharmaceutical, and scientific field; Booklets about healthcare, pharmaceutical, and scientific field; Pamphlets in the healthcare, pharmaceutical, and scientific field; Leaflets in the healthcare, pharmaceutical, and scientific field; Informational flyers in the healthcare, pharmaceutical, and scientific field; Brochures in the healthcare, pharmaceutical, and scientific field; Catalogues in the healthcare, pharmaceutical, and scientific field; information sheets in the nature of printed booklets in the healthcare, pharmaceutical, and scientific field; scrapbooks; notebooks; photographs; photographic prints; pictures; illustrations; printed images, namely, comics; posters; printed educational instructional training and teaching materials in the healthcare, pharmaceutical, and scientific field;, not including apparatus; stationery and educational supplies, namely, note books; artists' materials and writing materials, namely, pencils; writing instruments; paper; stationery cards; greeting cards; Christmas cards; all in the healthcare, pharmaceutical and scientific fieldACTIVE—
035Advertising marketing and promotional services; development of marketing strategies and concepts; Operational business assistance to enterprises for others in the pharmaceutical field; business management consulting in relation to marketing production, sales; business planning and strategy development services; business risk management services; Providing business information in the pharmaceutical field; Providing information in the field of economics; Provision of market research information; analysis of market research data and statistics featuring the issuance of reports; public relations services; advertising and publicity services in the nature of product launch services; business consultation and management regarding launching of new products; business advisory services relating to product development and the exploitation of inventions; brand consultancy services in the nature of Brand imagery consulting; advertising and promotion services, namely, brand creation services; creating advertising material; placing advertisements for others; developing promotional campaigns for business; business evaluation of business expansion opportunities for others; publication of publicity texts and materials; all the aforesaid services in the field of pharmaceuticals onlyACTIVE—
041Education services, namely, providing live and on-line seminars, workshops, and courses in the healthcare, pharmaceutical and scientific field; provision of training and mentoring for the continuing education of pharmaceutical companies, healthcare organizations, medical device companies, diagnostics companies, nutraceuticals companies, professional societies, patient groups, and academic institutions in the healthcare, pharmaceutical and scientific field; Education services, namely, arranging, organizing, and conducting courses, lectures, seminars, and workshops for educational purposes in the healthcare, pharmaceutical and scientific field; Education services, namely, arranging, organizing, and conducting of conventions, congresses, conferences, and exhibitions for educational purposes, all in the healthcare, pharmaceutical and scientific field; arranging, organizing, and conducting educational and entertainment competitions in the healthcare, pharmaceutical and scientific field for others; Providing continuing business education courses in the healthcare, pharmaceutical and scientific field; computer based training for the continuing education of pharmaceutical companies, healthcare organizations, specialist devices companies, diagnostics companies, nutraceuticals companies, professional societies, patient groups, and academic institutions in the healthcare, pharmaceutical and scientific field; provision of training courses for the continuing education of pharmaceutical companies, healthcare organizations, medical device companies, diagnostics companies, nutraceuticals companies, professional societies, patient groups, and academic institutions in the healthcare, pharmaceutical and scientific field; provision of training courses in strategic planning relating to advertising promotion, marketing, all in the healthcare, pharmaceutical and scientific field; Providing news in the nature of current event reporting; Publishing of electronic publications for others; publication of printed matter not for advertising or publicity purposes, namely, printed publications, texts, books, magazines, newsletters, journals, periodicals, almanacs, diaries, calendars, manuals, programs, booklets, pamphlets, leaflets, flyers, brochures, catalogues, information sheets, scrapbooks, notebooks, photographs, photographic prints, pictures, illustrations, printed images, posters, and instructional, training, and teaching printed materials all in the healthcare, pharmaceutical, and scientific fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 22, 2026EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Sep 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 22, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 22, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 3, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Feb 3, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jan 27, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 31, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Jul 16, 2024ES75TEAS SECTION 71 & 15 RECEIVED—
May 31, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 19, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 19, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 19, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 19, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 17, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 16, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 29, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 29, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 17, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 17, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2018TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jun 11, 2018OP.TOPPOSITION TERMINATED NO. 999999—
Jun 11, 2018OP.DOPPOSITION DISMISSED NO. 999999—
Feb 24, 2017OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 8, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 8, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 30, 2017DOCKASSIGNED TO EXAMINER—
Sep 16, 2016RFNPREFUSAL PROCESSED BY IB—
Aug 1, 2016OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 28, 2016OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Jul 28, 2016OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Apr 29, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 29, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 29, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2016GPNXNOTIFICATION PROCESSED BY IB—
Mar 9, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 9, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 9, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 17, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 21, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 24, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 24, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 24, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 3, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 3, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 3, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 3, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 2, 2015RFNTREFUSAL PROCESSED BY IB—
Sep 15, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 15, 2015RFRRREFUSAL PROCESSED BY MPU—
Sep 15, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 14, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2015RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Sep 13, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 12, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2015DOCKASSIGNED TO EXAMINER—
Sep 4, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance